Killian Meara

VAX-24 elicited substantial immunoglobulin G (IgG) and opsonophagocytic assay (OPA) immune responses at 1-month after the third dose across all doses studied.

This year’s conference is taking place from April 10 to 12 in Austin, Texas.

Patients treated with the therapy showed significantly less progression of structural damage compared to patients who received placebo at week 24.

A majority of donors said that environmental concerns were an extremely important reason to practice safe medication disposal.

A study found that patients who acquired a SARS-CoV-2 infection during pregnancy had a lower risk of developing long COVID compared to those who were not pregnant.

In this episode of the podcast, Shawn and Jesse outline 3 key principles about teamwork that can drive success in the pharmacy.

Black women and those living in Southern states had the highest rates of maternal mortality.

Investigators said that targeted education and interventions are key to the long term success of community pharmacy immunization programs.

Lydia Newsom, PharmD, discusses injection techniques, managing side effects, and the importance of collaboration between the healthcare team.

Jeffrey Bratberg, PharmD and Madi Hartling, a 2025 PharmD candidate, discuss the lack of pharmacists in medical shows and how pharmacists are typically portrayed negatively in media.

Nicole Cieri-Hutcherson, PharmD, BCPS, MSCP, FCCP, clinical associate professor at University at Buffalo, discusses how pharmacists can implement an injectable contraception program.

Xyngari resulted in significant improvements in IGA treatment success, inflammatory lesion count, and non-inflammatory lesion count compared to placebo.

A conversation with Rob Frankil, RPh, executive director of the Philadelphia Association of Retail Druggists.

The decision makes the therapy the first oral antibiotic treatment approved for uUTIs in over 20 years.

Lydia Newsom, PharmD, discusses how to support patients who are struggling with injection techniques or gastrointestinal side effects of GLP-1s.

The decision makes the RNAi therapeutic the only therapy approved by the FDA to treat ATTR-CM and hATTR-PN.

Nicole Cieri-Hutcherson, PharmD, BCPS, MSCP, FCCP, discusses tips for implementing pharmacist-administered injectable contraception programs.

Lydia Newsom, PharmD, discuses how pharmacists can support patients using GLP-1s.

Nicole Cieri-Hutcherson, PharmD, BCPS, MSCP, FCCP, clinical associate professor at University at Buffalo, discusses how pharmacists and patients view injectable contraception.

Control-IQ+ was associated with a greater reduction in glycated hemoglobin compared to a continuous glucose monitor alone.

A recent study found that continuous glucose monitors could help improve patient comfort, reduce resource use, and improve outcomes.

George Van Antwerp, MBA, discusses how the role of the pharmacist will evolve with the integration of precision medicine into the health systems setting.

A conversation with Lydia Newsom, PharmD, clinical associate professor of pharmacy practice at Mercer University College of Pharmacy.

The top reported barriers to providing buprenorphine included regulatory and administrative, operational and attitudinal, and patient-related challenges.

A conversation with Nicole Cieri-Hutcherson, PharmD, BCPS, MSCP, FCCP, clinical associate professor at University at Buffalo.

George Van Antwerp, MBA, senior vice president of Product Innovation and Strategic Planning at Prime Therapeutics, discusses how pharmacists can help patients decide which digital tools are best for them.

This year’s meeting will take place from March 21 to 24 in Nashville, Tennessee.

A conversation with Todd Bertoch, MD, chief medical officer for pain research at CenExel and an investigator on the ALLEVIATE-2 trial.

Ensitrelvir demonstrated a 67% relative risk reduction of developing symptomatic COVID-19 in household contact patients.

A conversation with Chelsee Jensen, PharmD, BCPS, director of formulary management at the Mayo Clinic.